BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9247348)

  • 1. Heparin in calcification prevention of porcine pericardial bioprostheses.
    Chanda J; Kuribayashi R; Abe T
    Biomaterials; 1997 Aug; 18(16):1109-13. PubMed ID: 9247348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalently bonded heparin to alter the pericardial calcification.
    Vasudev SC; Moses LR; Sharma CP
    Artif Cells Blood Substit Immobil Biotechnol; 2000 May; 28(3):241-53. PubMed ID: 10852675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of calcification in glutaraldehyde-treated porcine aortic and pulmonary valves.
    Chanda J; Kuribayashi R; Abe T
    Ann Thorac Surg; 1997 Oct; 64(4):1063-6. PubMed ID: 9354528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the dog a useful model for accelerated calcification study of cardiovascular bioprostheses?
    Chanda J; Kuribayashi R; Abe T; Sekine S; Shibata Y; Yamagishi I
    Artif Organs; 1997 May; 21(5):391-5. PubMed ID: 9129770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitigation of calcification and cytotoxicity of a glutaraldehyde-preserved bovine pericardial matrix: improved biocompatibility after extended implantation in the subcutaneous rat model.
    Neethling WM; Glancy R; Hodge AJ
    J Heart Valve Dis; 2010 Nov; 19(6):778-85. PubMed ID: 21214104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the chitosan posttreatment in calcification prevention of the glutaraldehyde-treated porcine aortic noncoronary cusp implanted in the right ventricular outflow tract in dogs.
    Kuribayashi R; Chanda J; Abe T
    Artif Organs; 1996 Jul; 20(7):761-6. PubMed ID: 8828765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of released aspirin/heparin for preventing bovine pericardial calcification.
    Vasudev SC; Chandy T; Sharma CP; Mohanty M; Umasankar PR
    Artif Organs; 2000 Feb; 24(2):129-36. PubMed ID: 10718766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices.
    Jayakrishnan A; Jameela SR
    Biomaterials; 1996 Mar; 17(5):471-84. PubMed ID: 8991478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-generation valved conduit: an experimental study.
    Chanda J; Kuribayashi R; Abe T
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):218-23. PubMed ID: 9270639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amide cross-linking: an alternative to glutaraldehyde fixation.
    Girardot JM; Girardot MN
    J Heart Valve Dis; 1996 Sep; 5(5):518-25. PubMed ID: 8894992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin coupling in inhibition of calcification of vascular bioprostheses.
    Chanda J; Kuribayashi R; Abe T
    Biomaterials; 1999 Oct; 20(19):1753-7. PubMed ID: 10509185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat treatment mitigates calcification of valvular bioprostheses.
    Carpentier SM; Chen L; Shen M; Fornes P; Martinet B; Quintero LJ; Witzel TH; Carpentier AF
    Ann Thorac Surg; 1998 Dec; 66(6 Suppl):S264-6. PubMed ID: 9930461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved calcification resistance and biocompatibility of tissue patch grafted with sulfonated PEO or heparin after glutaraldehyde fixation.
    Lee WK; Park KD; Kim YH; Suh H; Park JC; Lee JE; Sun K; Baek MJ; Kim HM; Kim SH
    J Biomed Mater Res; 2001; 58(1):27-35. PubMed ID: 11152994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms.
    Vyavahare N; Hirsch D; Lerner E; Baskin JZ; Schoen FJ; Bianco R; Kruth HS; Zand R; Levy RJ
    Circulation; 1997 Jan; 95(2):479-88. PubMed ID: 9008467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model.
    Weissenstein C; Human P; Bezuidenhout D; Zilla P
    J Heart Valve Dis; 2000 Mar; 9(2):230-40. PubMed ID: 10772041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid extraction attenuates the calcific degeneration of bovine pericardium used in cardiac valve bioprostheses.
    Rossi MA; Braile DM; Teixeira MD; Souza DR; Peres LC
    J Exp Pathol (Oxford); 1990 Apr; 71(2):187-96. PubMed ID: 2331406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No-react detoxification process: a superior anticalcification method for bioprostheses.
    Abolhoda A; Yu S; Oyarzun JR; Allen KR; McCormick JR; Han S; Kemp FW; Bogden JD; Lu Q; Gabbay S
    Ann Thorac Surg; 1996 Dec; 62(6):1724-30. PubMed ID: 8957377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of an epoxy-fixed pericardial patch with or without ionically bound heparin in a canine model.
    Chang Y; Sung H; Chiu Y; Lu J
    Int J Artif Organs; 1997 Jun; 20(6):332-40. PubMed ID: 9259210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of calcification of heart valve bioprostheses: an experimental study in rat.
    Chanda J
    Ann Thorac Surg; 1995 Aug; 60(2 Suppl):S339-42. PubMed ID: 7646184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcification of pericardial tissue pretreated with different amino acids.
    Jorge-Herrero E; Fernández P; Escudero C; García-Páez JM; Castillo-Olivares JL
    Biomaterials; 1996 Mar; 17(6):571-5. PubMed ID: 8652775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.